Immune Composition and Immunotherapy Outcomes of Mesothelioma With BAP1, CDKN2A, MTAP, and NF2 Alterations

Ibiayi Dagogo‐Jack, Owen Mitchell, Elizabeth Codd, Annie Li, Dawn Mitchell, Samantha E. Flynn, Nanna Sivamanoharan, Patrick M. Reeves, Mark C. Poznansky, Ivan Valiev, A. Kosmin, Beow Y. Yeap, Grace Hambelton, A. John Iafrate, Jochen K. Lennerz, Yin P. Hung, Hedy L. Kindler